K. K. Oros

发表

Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours

C. Greenwood, A. Mes-Masson, D. Provencher, 2011, PloS one.

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population

J. Ragoussis, C. Greenwood, A. Mes-Masson, 2022, Cancers.

Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations

C. Greenwood, A. Mes-Masson, W. Foulkes, 2004, International journal of cancer.

Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance.

C. Greenwood, A. Mes-Masson, P. Tonin, 2013, Cancer genetics.

A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene

Trevor J Pugh, J. Ragoussis, C. Greenwood, 2021, Genome medicine.

The genetic analysis of a founder Northern American population of European descent identifies FANCI as a candidate familial ovarian cancer risk gene

J. Ragoussis, C. Greenwood, A. Mes-Masson, 2020, medRxiv.

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

Ryan D. Morin, Lauren C. Chong, C. Greenwood, 2015, Clinical Cancer Research.

The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome

C. Greenwood, A. Mes-Masson, J. Madore, 2012, PloS one.

Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

Ryan D. Morin, Lauren C. Chong, C. Greenwood, 2016, Blood.

New insights into the role of intra-tumor genetic heterogeneity in carcinogenesis: identification of complex single gene variance within tumors

C. Greenwood, M. Basik, Chunlin Wang, 2018, Journal of Cancer Metastasis and Treatment.

Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases

Trevor J Pugh, J. Ragoussis, C. Greenwood, 2023, Frontiers in Oncology.

Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families

Anne-Marie Mes-Masson, A. Mes-Masson, W. Foulkes, 2006, BMC Medical Genetics.

Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent

A. Mes-Masson, W. Foulkes, D. Provencher, 2006, Clinical genetics.

Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer

J. Ragoussis, A. Mes-Masson, D. Provencher, 2023, medRxiv.

Analysis of genomic abnormalities in tumors: a review of available methods for Illumina two-color SNP genotyping and evaluation of performance.

C. Greenwood, A. Mes-Masson, P. Tonin, 2013, Cancer genetics.